FALCO HOLDINGS Co., Ltd. (4671.T)

JPY 2332.0

(0.39%)

Market Cap (In JPY)

24.88 Billion

Revenue (In JPY)

43 Billion

Net Income (In JPY)

1.66 Billion

Avg. Volume

20.17 Thousand

Currency
JPY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1981.0-2539.0
PE
-
EPS
-
Beta Value
0.23
ISIN
JP3802650006
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. Tadashi Yasuda
Employee Count
-
Website
https://www.falco-hd.co.jp
Ipo Date
2004-10-29
Details
FALCO HOLDINGS Co., Ltd., a medical service company, primarily provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan. It offers clinical testing services in the fields of genetic tests, biochemistry, hematology, pathology, immunology, microbiology, and radio immunoassay; genetic testing services; and genomic-based drug discovery and biotechnology drug development services. The company also provides medical information technology services; food sanitation and environmental testing services; and food related genetic testing services to food manufacturers, retailers, and restaurants. In addition, it is involved in the dispensing pharmacies and drugstores business; and development and sale of various medical information systems, including @home Dr. electronic medical charts for clinics with concentrated clinical testing, as well as TASCAL for ASP, a medical support system. The company was founded in 1962 and is headquartered in Kyoto, Japan.